Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
Allergan
|
| gptkbp:awards |
industry recognition
|
| gptkbp:clinicalTrials |
ongoing
gene therapy neurology oncology stem cell therapy trauma care orthopedics sports medicine dermatology biomaterials infectious diseases wound care tissue repair surgical mesh veterinary medicine cosmetic surgery burn treatment surgical wounds cell therapy plastic surgery reconstructive surgery gynecology urology cardiovascular chronic wounds pressure ulcers diabetic ulcers biologic dressings extracellular matrix products scaffold technology pediatric_care skin_grafts |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:communityInvolvement |
philanthropic initiatives
|
| gptkbp:conference |
medical conferences
|
| gptkbp:employees |
approximately 500
|
| gptkbp:focus |
tissue regeneration
|
| gptkbp:founded |
2000
|
| gptkbp:headquarters |
gptkb:Branchburg,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Allergan's LifeCell
|
| gptkbp:industry |
healthcare
|
| gptkbp:innovation |
tissue engineering
|
| gptkbp:market |
global
|
| gptkbp:parentCompany |
AbbVie
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:patentCitation |
numerous patents filed
|
| gptkbp:products |
AlloDerm
Regranex Strattice |
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:researchAndDevelopment |
biologics
|
| gptkbp:specializesIn |
regenerative medicine
|
| gptkbp:sustainabilityPractices |
environmental responsibility
|
| gptkbp:website |
www.lifecell.com
|